 Connection
Andrew Libby to Peroxisome Proliferator-Activated Receptors
This is a "connection" page, showing publications Andrew Libby has written about Peroxisome Proliferator-Activated Receptors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.229 |
|
|
|
-
Libby AE, Jones B, Lopez-Santiago I, Rowland E, Levi M. Nuclear receptors in the kidney during health and disease. Mol Aspects Med. 2021 04; 78:100935.
Score: 0.178
-
Liggett JR, Kang J, Ranjit S, Rodriguez O, Loh K, Patil D, Cui Y, Duttargi A, Nguyen S, He B, Lee Y, Oza K, Frank BS, Kwon D, Li HH, Kallakury B, Libby A, Levi M, Robson SC, Fishbein TM, Cui W, Albanese C, Khan K, Kroemer A. Oral N-acetylcysteine decreases IFN-? production and ameliorates ischemia-reperfusion injury in steatotic livers. Front Immunol. 2022; 13:898799.
Score: 0.050
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|